I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Disitamab Vedotin Alone or in Combination With Immune Check..:
Wang, Anbang
;
Chen, Ming
;
Li, Duocai
...
Clinical Genitourinary Cancer. 22 (2024) 3 - p. 102085 , 2024
Link:
https://doi.org/10.1016/j.clgc.2024.102085
RT Journal T1
Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.clgc.2024.102085&Exemplar=1&LAN=DE A1 Wang, Anbang A1 Chen, Ming A1 Li, Duocai A1 Shi, Jiazi A1 Tang, Wenbin A1 Zhang, Zongqin A1 Ren, Shancheng PB Elsevier BV YR 2024 SN 1558-7673 JF Clinical Genitourinary Cancer VO 22 IS 3 SP 102085 LK http://dx.doi.org/https://doi.org/10.1016/j.clgc.2024.102085 DO https://doi.org/10.1016/j.clgc.2024.102085 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)